FDA Determines Regulatory Review Period for PROFENDER Patent Extension

Summary

The Food and Drug Administration has officially confirmed the regulatory review period for PROFENDER, an animal drug product, in accordance with federal regulations, following a patent extension application submitted to the Director of Patents and Trademarks at the Department of Commerce.